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352Objective: Retrograde aortic arch malperfusion after ductal stenting can be life-threatening after univentricular
hybrid palliation. Arch perfusion can be maintained with a main pulmonary artery to innominate artery shunt
placed during the stage I procedure: a ‘‘reverse Blalock-Taussig shunt.’’
Methods: A retrospective review of 37 infants who underwent hybrid palliation from January 2004 to March
2010 was performed. The infants were divided into 2 groups, those with (group I, n ¼ 16) and those without
(group II, n ¼ 21) a reverse Blalock-Taussig shunt.
Results: At the initial palliation, no differences were found in the demographics, systolic or diastolic pressures,
or ventricular or atrioventricular valve function between the 2 groups. Group I had more infants with aortic atre-
sia (P<.01) and smaller ascending aortas (P<.01). Before stage II, the retrograde aortic Doppler flow velocity
increased in group I (P<.01) and was unchanged in group II. The reintervention rates before stage II were sim-
ilar between the 2 groups. Before stage II, the ventricular end-diastolic pressure, left and right pulmonary artery
pressures and diameters, and mixed venous and arterial saturations were similar between the 2 groups. The com-
plication rates between the 2 groups were not significantly different, although a nonsignificant trend towardmore
neurologic complications was noted in group I. The Kaplan-Meier survival estimate at 1 year was similar be-
tween the 2 groups (63% for group I vs 71% for group II).
Conclusions: The presence of a reverse Blalock-Taussig shunt was not associated with more adverse events than
those without. Gradual retrograde arch obstruction occurs commonly in palliated infants with aortic atresia. A
reverse Blalock-Taussig shunt might play an important role to address the potential of retrograde obstruction,
augmenting arch blood flow. (J Thorac Cardiovasc Surg 2013;146:352-7)The so-called hybrid palliation (bilateral pulmonary artery
[PA] bands and a ductal stent) has emerged as an alternative
to Norwood palliation for infants with hypoplastic left heart
syndrome or its variants.1-3 The potential, but unproved,
advantage of hybrid palliation is the avoidance of
circulatory bypass and aortic arch reconstruction in the
neonatal period, shifting such procedures to later in life.
A potential problem with this strategy is either immediate
or delayed obstruction in the aortic isthmus after ductal
stent deployment. This obstruction can compromise
retrograde aortic arch flow, which supports, in the extreme
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The Journal of Thoracic and Cardiovascular Surgperfusion. A potential solution is the placement of a main
PA to innominate artery shunt, analogous to a Blalock-
Taussig (BT) shunt, which we have designated the ‘‘reverse
BT (revBT) shunt.’’4 This connection can provide a source
of blood flow to the ascending aortic arch if the retrograde
arch flow from the isthmus becomes compromised. Few
centers perform a revBT shunt during hybrid palliation,
and little is known regarding the outcomes and potential ad-
vantages and disadvantages of the procedure. In the present
study, we reviewed our experience during hybrid palliation
in those infants with and without a revBT shunt.METHODS
A retrospective chart reviewwas conducted of all infants with hypoplas-
tic left heart syndrome or 1 of its variants, who had undergone hybrid single
ventricle palliation from January 2004 toMarch 2010. The Research Ethics
Board at the Hospital for Sick Children approved the study, and patient and
family consent was waived owing to the retrospective nature of the study.
The form of surgical palliation (hybrid [with or without a revBT shunt],
Norwood, or primary transplantation) was discussed at an interdisciplinary
conference after presenting the options to the family. No specific decision-
making protocol was applied for the form of surgical palliation. The revBT
shunt was placed after PA banding, avoiding the pulmonary valve ring to
the innominate artery using a 3.5-mm polytetrafluoroethylene graft. The
use of the revBT shunt was approved by the Surgical Innovations Ethics
Committee, and the experimental nature was explained to each family.3ery c August 2013
Abbreviations and Acronyms
AVVR ¼ atrioventricular valve regurgitation
BT ¼ Blalock-Taussig
ECMO ¼ extracorporeal membrane oxygenation
PA ¼ pulmonary artery
PVR ¼ pulmonary valve regurgitation
revBT ¼ reverse BT
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DEchocardiogaphic Assessment
Echocardiography was performed using a Phillips ATL (Advanced
Technology Laboratories, Bothell, Wash), Philips IE-33 (Philips Medical
systems, Eindhoven, The Netherlands), or Vivid 7 (GEHealthcare, Wauke-
sha, Wis) system. The echocardiograms at diagnosis, immediately after hy-
brid palliation, before hospital discharge, and before the comprehensive
stage II procedure (arch reconstruction and a cavopulmonary connection)
were reviewed (n ¼ 27). Digital images were stored and analyzed offline
with commercially available software (SyngoDynamics, Siemens Medical
Systems, Erlangen, Germany). Ventricular function was graded visually
(1, normal; 2, mild impairment; 3, moderate; and 4, severe impairment),
and the degree of atrioventricular valve regurgitation (AVVR) and pulmo-
nary valve regurgitation (PVR) was graded (1, none/trace; 2, mild; 3, mod-
erate; and 4, severe) according to the color flow regurgitant jet, as
previously described.5,6 From a suprasternal long-axis view, isthmus flow
was measured at the base of the left subclavian artery. The flow profile
was outlined manually to measure the maximal flow velocity, and the
velocity–time integral, with 3 consecutive heart beats, was measured and
averaged. The retrograde/antegrade velocity–time integral ratio was calcu-
lated and considered dominantly retrograde if the ratio was>1. The pres-
ence of flow in the revBT shunt was determined; however, because of the
incident angle, the flow velocity could not be assessed.
Catheterization and Angiography
The invasive hemodynamic studies and angiograms before stage II sur-
gery were reviewed. The diameters of the right and left PAs were measured
at the hilum, proximal to the takeoff of the branching vessels. A Nakata in-
dex was calculated as the sum of the right and left PA cross-sectional areas
indexed to the child’s body surface area.7
Statistical Analysis
The data are presented as the mean  standard deviation. Continuous
variables were compared using the Mann-Whitney U test and Student t
test. Dichotomous and categorical variables were analyzed using Fisher’s
exact test and the chi-square test. Paired data were examined using paired
2-tailed t tests. Kaplan-Meier curves were constructed to determine the
freedom from death or transplantation, and the survival rate was compared
between the 2 groups using a log-rank test.
RESULTS
Patient Characteristics
A total of 48 consecutive neonates underwent hybrid
palliation. Excluded from the present review were those
neonates who underwent hybrid palliation as a bridge to
transplantation (n ¼ 7), a salvage procedure during extra-
corporeal membrane oxygenation (ECMO) support (n ¼ 1)
or as an interim procedure before biventricular repair
(n ¼ 3). The remaining 37 neonates included in the study
cohort were divided into 2 groups: those with (group I) andThe Journal of Thoracic and Cathose without (group II) a revBT shunt. The patient charac-
teristics and diagnoses are listed in Table 1. In group I, 16
neonates underwent palliation at a median age of 6.5 days
(mean, 7.4  4.8 days) and median weight of 3.3 kg
(mean, 3.2  0.6 kg). The 21 neonates in group II under-
went hybrid palliation without a revBT shunt at a median
age of 7.0 days (mean, 13.5  24 days) and median weight
of 3.2 kg (mean, 3.2  0.5 days). In group II, 4 neonates
had aortic atresia; 2 procedures were abandoned because
of patient instability during the procedure (electrocardio-
graphic changes of ischemia). The other 2 neonates had
an ascending aorta more than 3 mm in diameter and pre-
sented early in our experience before the decision to place
a revBT shunt in neonates with aortic atresia. No demo-
graphic differences were seen between the 2 groups.
Echocardiographic Findings
Not unexpectedly, the group I infants had a significantly
smaller ascending aorta (2.4  1.2 mm vs 5.0  1.9 mm,
P<.01) and more commonly aortic atresia (16/16 [100%]
vs 4/21 [19%]; P<.01) than those in group II (Table 2).
Although all neonates in group I by anatomic definition
had retrograde arch flow, 11 neonates (52%) in group II
had a dominant retrograde arch flow pattern. No significant
difference was found in ventricular function or the degree
of AVVR or PVR at the initial examination between the 2
groups.
Interstage Echocardiography: After Stage I and
Before Stage II
Echocardiographic studies were obtained before stage II
at 186  24 and 198  38 days of age in group I and II, re-
spectively (Table 3). All revBT shunts were patent, as deter-
mined by echocardiography or angiography. No significant
differences were found in ventricular function, AVVR, or
PVR during this period in either group. Before stage I, no
difference was found in retrograde flow between the 2
groups; however, in group I, the retrograde arch flow peak
velocities increased significantly (P < .01). In group II
(those with dominant retrograde arch flow, n ¼ 11), no sig-
nificant increase was seen in the velocity (P¼ .30). In the 3
group II infants (19%) with aortic atresia, the changes in
retrograde peak flow velocities were as follows: patient 1,
from 0.95 to 2.2 m/s; patient 2, 1.5 to 2.6 m/s; and patient
3, 1.7 to 2.4 m/s. Although the analysis of the entire group
showed no statistically significant difference, a clear trend
was seen toward progressive arch malperfusion in these
infants.
Subsequent Interventions
Intervention on the atrial septum was performed in 10 of
16 (63%) infants in group I and 11 of 21 infants (52%) in
group II. No significant difference was seen in the age at in-
tervention between the 2 groups (group I, 52  52 days;rdiovascular Surgery c Volume 146, Number 2 353
TABLE 1. Patient characteristics and diagnosis
Variable
Group I
(n ¼ 16)
Group II
(n ¼ 21) P value
Male gender (%) 8 (50) 7 (33) .31
Antenatal diagnosis (%) 9 (56) 16 (76) .20
Age at stage I (d) 7.4  4.8 13.5  24 .46
Weight at stage I (kg) 3.2  0.6 3.2  0.5 .94
Hypoplastic left heart syndrome —
AA/MA 12 3
AA/MS 3 1
AS/MA 1
AS/MS 7
TA, TGA 1 1
TAPVD* 1
Unbalanced AVSD 5
DORV, CoA 2
DILV, TGA 1
AA,Aortic atresia;MA,mitral atresia;MS,mitral stenosis; AS, aortic stenosis; TA, tri-
cuspid atresia; TGA, transposition of great arteries; TAPVD, total anomalous pulmo-
nary venous drainage; AVSD, atrioventricular septal defect; DORV, double-outlet
right ventricle; CoA, coarctation of aorta; DILV, double-inlet left ventricle. *Patient
with TAPVD had underlying diagnosis of AA/MA.
TABLE 3. Interstage echocardiographic findings
Group After stage I Before stage II P value
I (n ¼ 11)
Age (d) 26  9.6 186  24 —
Ventricular function grade 1.2  0.4 1.1  0.3 .64
AVVR 2.0  0.4 1.6  0.5 .09
PVR 1.5  0.5 1.4  0.5 .67
Retrograde arch flow (m/s) 1.2  0.2 1.9  0.4 <.01
II (n ¼ 16)
Age (d) 26  16 198  38 —
Ventricular function grade 1.0  0.0 1.1  0.3 .69
AVVR 1.8  0.5 2.0  0.5 .28
PVR 1.1  0.3 1.3  0.5 .59
Retrograde arch flow (m/s)* 1.6  0.5 1.8  0.6 .3
AVVR, Atrioventricular valve regurgitation; PVR, pulmonary valve regurgitation.
*Nine patients had dominant retrograde flow.
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Dmedian, 42 days; vs group II, 58  34 days; median, 57
days; P ¼ .32). An intervention on the ductal stent was per-
formed in 3 of 16 infants (19%) in group I and 2 of 21
(10%) in group II at 12, 49, and 123 days of age in group
I and 13 and 14 days of age in group II. One child in group
I underwent coil embolization of an aortopulmonary collat-
eral 4 months before the comprehensive stage II procedure.
The intervention rates before stage II were not different be-
tween the 2 groups (P ¼ .21).Growth, PA Size, and Hemodynamic Findings Before
Stage II
Somatic growth was not significantly different nor was
the size of the branch PAs, with Nakata indexes also similarTABLE 2. Preoperative echocardiographic findings
Variable Group I Group II P value
Before stage I
Patients (n) 16 21
Ascending aorta size (mm) 2.4  1.2 5.0  1.9 <.01
Aortic atresia (n) 16 (100%) 4 (19%) <.01
Retrograde arch flow (n) 16 (100%) 11 (52%) <.01
Ventricular function grade 1.3  0.7 1.1  0.5 .42
AVVR 1.4  0.5 1.2  0.8 .53
PVR 1.2  0.4 1.1  0.2 .18
Before stage II
Patients (n) 11 16
Ventricular function grade 1.1  0.3 1.1  0.3 .87
AVVR 1.6  0.5 2.0  0.5 .19
PVR 1.4  0.5 1.3  0.5 .55
Retrograde arch flow (m/s) 1.9  0.4 1.8  0.6* .29
AVVR, Atrioventricular valve regurgitation; PVR, pulmonary valve regurgitation.
*Nine patients had dominant retrograde flow.
354 The Journal of Thoracic and Cardiovascular Surgbetween the 2 groups (Table 4). The hemodynamic out-
comes before stage II were not different between the 2
groups (Table 4). In particular, no difference were found
in diastolic blood pressure, mixed venous saturation, or
chamber end-diastolic pressure.Complications
In group I, 10 complications occurred in 7 children. One
neonate developed hypotension after insertion of the revBT
shunt, and the shunt was clipped, with recovery of blood
pressure. This same child developed necrotizing enterocoli-
tis the following day. Another child developed recurrent
atrial flutter requiring cardioversion during the procedure
and experienced bilateral, watershed cerebral infarctions.
Eight additional complications occurred after the index hy-
brid procedure, including atrial flutter and migration of an
atrial stent. The atrial stent was deployed 7 days after stage
I to address a highly restrictive septal defect; however, the
stent embolized, requiring surgical removal. The neurologicTABLE 4. Catheterization data before stage II
Variable
Group I
(n ¼ 11)
Group II
(n ¼ 16) P value
Age (mo) 3.8  0.9 4.2  1.1 .34
Body weight (kg) 5.6  1.0 5.8  1.2 .65
Systolic blood pressure (mm Hg) 83.6  11.7 88.8  8.7 .14
Diastolic blood pressure (mm Hg) 45.6  9.5 46.6  6.9 .54
Ventricular end-diastolic pressure
(mm Hg)
7.5  2.6 6.8  2.6 .47
Mean right PA pressure (mm Hg) 10.8  2.8 11.9  3.7 .45
Mean left PA pressure (mm Hg) 13.5  4.5 13.8  5.5 .89
Qp/Qs 0.95  0.4 0.88  0.4 .63
Finger tip oximetry (room air) (%) 76.8  4.9 80.1  6.5 .22
Mixed venous saturation (%) 53.7  9.3 59.7  9.9 .14
Right PA diameter (mm) 8.1  1.3 7.5  1.9 .43
Left PA diameter (mm) 7.1  1.7 6.9  1.7 .77
Nakata index 323  83 292  150 .54
PA, Pulmonary artery; Qp/Qs, pulmonary-to-systemic flow ratio.
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FIGURE 1. Outcomes of patients undergoing hybrid palliation with (group I) or without (group II) reverse Blalock-Taussig shunt (revBT). BCPS, Bidi-
rectional cavopulmonary shunt; þRBT, reverse Blalock-Taussing shunt.
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Dcomplications were as follows: 1 child with combined right
parietal and frontal cerebral infarctions, 1 left cerebral hem-
orrhage (which occurred 2 months after the procedure), and
the previously mentioned patient with bilateral watershed
infarctions secondary to hypotension. Three children devel-
oped necrotizing enterocolitis during the initial hospitaliza-
tion, 1, 1, and 9 days after stage I.
In group II, 10 complications developed, 7 during the
stage I procedure. Two children required ECMO support
secondary to hypotension, and two developed ischemic
electrocardiographic changes during surgery (with one
abandonment of a planned revBT shunt). Intraoperative
supraventricular tachycardia was noted in 3 neonates. Three
complications occurred after stage I, including spontaneous
loosening of one left PA band, one right femoral artery
thrombosis, and one left diaphragmatic paralysis. No neuro-
logic complications occurred in the group II cohort. No
statistically significant difference was found in the compli-
cation rates between the 2 groups.
Outcomes
Of the 16 infants in group I and 21 in group II, 11 (69%)
and 17 (81%) underwent the stage II procedure. One infant
in group II underwent attempted revBT shunt placement 2
days after the index hybrid palliation. This infant subse-
quently required Norwood palliation at 102 days and then
progressed to a bidirectional cavopulmonary connection
at 9 months of age (290 days after the index hybrid
palliation). No statistically significant difference was
found in survival to the stage II procedure between the 2
groups (P ¼ .74). At the last follow-up visit, 5 children in
group I and 8 in group II were awaiting Fontan palliationThe Journal of Thoracic and Caand 5 infants in group I and 7 in group II had undergone
a Fontan procedure (Figure 1). The Kaplan-Meier curve
for freedom from death or transplantation is shown in
Figure 2, with no difference in the 1-year death or
transplantation-free survival between the 2 groups (group
I, 63%, and group II, 76%, log rank P ¼ .47). Of the 4 ne-
onates with aortic atresia who did not receive a revBT shunt,
the 2 with an ascending aorta more than 3 mm in diameter
underwent the stage II procedure uneventfully. Of the 2 ne-
onates whose arch was less than 3 mm, 1 died after stage I
and the other required ECMO to rehabilitate the myocar-
dium before stage II. All 3 patients were awaiting Fontan
palliation at last follow-up.
DISCUSSION
So-called hybrid palliation (PA banding and ductal stent-
ing) has become an alternative to the Norwood procedure.
As an evolving palliation strategy, a variety of issues and
complications are becoming apparent. One such issue is
the management of present or potential retrograde arch mal-
perfusion.8 In the hybrid circulation with aortic atresia, cor-
onary and cerebral perfusion is dependent on retrograde
arch flow. As such, retrograde arch obstruction will result
in coronary and cerebral vascular bed ischemia. The revBT
shunt was developed to provide an alternative source of up-
per body blood flow if retrograde arch flow became compro-
mised.4 What has not been established is the effect on the
clinical course for those neonates who had received a revBT
shunt.
In the present study cohort, no significant differences
were found in the overall stage II and 1-year survival for
those with and without a revBT shunt. All neonates in grouprdiovascular Surgery c Volume 146, Number 2 355
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FIGURE 2. Kaplan-Meier survival analysis comparing groups I and II. Data in parentheses indicate number of patients. No significant differencewas found
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DI had aortic atresia and, subsequently, a smaller ascending
aorta than those in group II, and, using a Norwood strategy,
such neonates were considered at greater risk.9,10 Others
have reported that an ascending aorta diameter less than 2
mm is a contraindication for bilateral PA banding.11 From
our cohort, the median ascending aorta size in group I
was 2 mm, with one half (n ¼ 8) having a diameter less
than 2 mm. Nonetheless, the outcomes of group I were
equivalent to those of group II.
The interstage echocardiographic data revealed that the
retrograde arch flow peak velocity in group I increase signif-
icantly over time, with no significant changes in group II.
These findings support the notion that those infants with
aortic atresia are at greater risk of progressive retrograde
flow obstruction. The question can be raised of whether
the revBT shunt in and of itself increases or potentiates pro-
gressive retrograde arch obstruction or whether it is related
to the child’s underlying anatomic substrate (aortic atresia
and severe hypoplasia of the ascending aorta). In this regard,
Stoica and colleagues8 found that neonates with aortic atre-
sia (with hybrid palliation but no revBT shunt) were more
likely to develop retrograde arch obstruction. The interstage
echocardiographic data from the present cohort showed the
absence of significant differences in ventricular function or
degree of AVVR in the 2 groups. These results suggest that
coronary perfusion in group I was secured, despite the prog-
ress in aortic isthmus obstruction by the presence of the
shunt. The rate of unplanned interstage procedures was
also not different between the 2 groups. Additionally, no sta-
tistically significant differences were found in the presence
of PVR before stage II between the 2 groups, suggesting that
the presence of the shunt (inserted near the pulmonary
valve) was not adversely affected.356 The Journal of Thoracic and Cardiovascular SurgPreviously published data from our institution and patient
cohort have shown that no differences in the right or left PA
diameters or Nakata index between infants undergoing ei-
ther Norwood or hybrid palliation.12,13 Similarly, in the
present study of hybrid, palliated neonates, no differences
were seen in the PA diameters or Nakata indexes between
the 2 groups. No demonstrable difference or detrimental
effect was found for the revBT shunt on PA growth. One
of the greatest concerns with the addition of a revBT
shunt is the potential for increased neurologic
complications related to the shunt. The incidence of
neurologic complications was greater in the revBT shunt
group, although it did not reach statistical significance. In
1 neonate with right cerebral infarction, the shunt had
been placed on the ipsilateral side and was considered
a likely source of thrombus. A second neonate had
recurrent atrial flutter and bilateral watershed cerebral
infarctions, which were attributed to hypotension and not
directly shunt related. The final infant experienced
a cerebral hemorrhage on the contralateral side of the
shunt 2 months after the procedure. This infant had been
treated with low-molecular-weight heparin, which was con-
sidered a significant contributing factor to the hemorrhage.
In contrast, the prevalence of neurologic deficits persisting
at discharge after a Norwood operation has been reported to
be 3%.14 One of the potential advantages of the hybrid
strategy is the avoidance of cardiac bypass in the neonatal
period, a documented risk factor for cerebral injury.15 We
could not fully determine whether a revBT shunt exposes
the infant to a greater risk of cerebral events owing to the
small numbers in the present study.
Between stages, strategies to address infants without
a revBT shunt who develop isthmic obstruction includeery c August 2013
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Dimmediate conversion to a Norwood circulation, stent de-
ployment within the stenotic aortic isthmus, an early stage
II procedure, and heart transplantation. In the present study,
2 infants in group II underwent a Norwood procedure. The
first infant experienced cardiovascular collapse during the
hybrid procedure. A revBT shunt was added, and the child
was supported with ECMO. A Norwood procedure was
electively performed after the cardiac function recovered.
A second infant could not undergo a comprehensive stage
II procedure because of pulmonary hypertension (due to
a loose PA band) and was converted to Norwood
circulation.
Stoica and colleagues8 reported that stent insertion in the
stenotic isthmus has proved to be an effective and durable
solution to isthmus obstruction. Once isthmus obstruction
has occurred, the risks of sudden death or myocardial failure
are much greater. What might be more important than solu-
tions to the address such problems once they have devel-
oped are approaches to protect the at-risk patient group,
with consideration of the addition of a revBT shunt to mod-
ulate such a complication. Our institutional practice is to
place a revBT shunt prophylactically as a proactive strategy
for those hybrid patients who are dependent on retrograde
flow or who are at high risk of progressive obstruction.
Study Limitations
The present study was a retrospective, nonrandomized re-
view of a small cohort from a single institution and thus had
the limitations intrinsic to those boundaries. Additionally,
the lack of an institutional protocol to allocate neonates to
a hybrid strategy with or without a revBT shunt regardless
of outflow anatomy could have avoided the possible bias in-
trinsic to retrospective review.
CONCLUSIONS
A revBT shunt was placed for infants thought to be at
greater risk of upper body ischemia from compromised ret-
rograde blood flow. The outcomes were equivalent to those
without a revBT shunt. Although the retrograde arch flow
velocity significantly increased in the group with a revBT
shunt, ventricular function and AVVR were preserved.
The cohort with a revBT shunt had comparable hemody-
namic findings, with no detrimental effects on PA
growth. The rates of unplanned interstage procedures andThe Journal of Thoracic and Cacomplications were not different between the 2 groups. A
revBT shunt showed a trend toward more neurologic com-
plications; however, the difference did not reach statistical
significance. Our findings have shown that a revBT shunt
can play an important role in hybrid palliation to address
the issue of potential retrograde arch obstruction.References
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